If AMPK does indeed suppress CSCs, we find ourselves in the paradoxical situation where inhibition of AMPK might inhibit the growth of the bulk of the tumour, while potentially also taking the brakes off the proliferation of tumour-initiating cancer stem cells. Here, PRKAB1 is linked to neoplasm.